Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 16/20 | 0.58 |
| ▸ | MAPK14 | Q16539 | 10/20 | 0.55 |
| ▸ | SRC | P12931 | 9/20 | 0.54 |
| ▸ | SYK | P43405 | 9/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6547744 | 0.94 | GSK3A (0.60) | GSK3AMAPK14SRCSYKLCK | |
| SCHEMBL6546894 | 0.91 | GSK3A (0.59) | GSK3AMAPK14SRCSYKLCK | |
| SCHEMBL6545708 | 0.89 | GSK3A (0.57) | GSK3AMAPK14SRCSYKLCK | |
| SCHEMBL6546837 | 0.89 | MAPK14 (0.61) | GSK3AMAPK14SRCSYKLCK | |
| SCHEMBL6546256 | 0.89 | GSK3A (0.69) | GSK3AMAPK14SRCSYKCXCL8 | |
| SCHEMBL6643812 | 0.86 | GSK3A (0.57) | GSK3AMAPK14SRCSYKCXCL8 | |
| SCHEMBL6546932 | 0.86 | GSK3A (0.65) | GSK3AMAPK14SRCSYKLCK | |
| SCHEMBL6547812 | 0.86 | GSK3A (0.58) | GSK3AMAPK14SRCSYKLCK | |
| SCHEMBL6547728 | 0.86 | GSK3A (0.58) | GSK3AMAPK14SRCSYKLCK | |
| SCHEMBL6547720 | 0.86 | GSK3A (0.58) | GSK3AMAPK14SRCSYKLCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1381592-A1 | 1,4-DISUBSTITUTED BENZO-FUSED COMPOUNDS | BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) | 2004-01-21 | — | — | EP | disclosed |
| WO-2002083628-A1 | 1,4-DISUBSTITUTED BENZO-FUSED COMPOUNDS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2002-10-24 | — | — | WO | disclosed |